SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the ...
Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, streamlines multiplex immunofluorescence (IF) for oncology and translational research with the launch of its ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...